CALEC surgery represents a groundbreaking advancement in the field of ocular medicine, offering new hope to patients suffering from serious eye damage.This innovative procedure, which stands for cultivated autologous limbal epithelial cells, utilizes stem cell therapy to regenerate the cornea's surface, a result achieved during a clinical trial led by experts at Mass Eye and Ear.